Related Experiment Video
Updated: Jun 22, 2026
08:00
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
Temozolomide in malignant gliomas: current use and future targets
J Lee Villano1, Tara E Seery, Linda R Bressler
1Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA. jvillano@uic.edu
Cancer Chemotherapy and Pharmacology
|June 23, 2009
Summary
Temozolomide (TMZ), an oral alkylating agent, is a tolerable and effective treatment for newly diagnosed glioblastoma when combined with radiotherapy. This summary reviews concerns, imaging, and pharmacology related to TMZ use and resistance.
Area of Science:
- Oncology
- Pharmacology
- Radiotherapy
Background:
- Temozolomide (TMZ) is an oral alkylating agent widely used for newly diagnosed glioblastoma.
- Its combination with radiotherapy significantly prolongs survival in these patients.
Purpose of the Study:
- To summarize developing concerns regarding Temozolomide (TMZ) use in malignant glioma treatment.
- To review imaging modalities for malignant gliomas.
- To discuss the pharmacology of TMZ, including its mechanism of action, dosing schedules, and resistance mechanisms.
Main Methods:
- Literature review and synthesis of current research on Temozolomide (TMZ).
- Analysis of data on glioblastoma treatment outcomes.
- Examination of pharmacological studies on TMZ.
Main Results:
- Temozolomide (TMZ) combined with radiotherapy is a standard treatment for newly diagnosed glioblastoma.
- Ongoing research addresses concerns about TMZ usage, optimal imaging techniques, and strategies to overcome treatment resistance.
- Understanding TMZ's pharmacology is crucial for optimizing patient outcomes.
Conclusions:
- Temozolomide (TMZ) remains a cornerstone in glioblastoma treatment, but challenges related to its use and resistance persist.
- Further research into TMZ pharmacology and resistance mechanisms is essential for improving therapeutic strategies.
- Comprehensive understanding of TMZ, imaging, and resistance is vital for oncologists.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.